Old Web
English
Sign In
Acemap
>
Paper
>
Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
2014
Tomas Kalincik
Dana Horakova
Tim Spelman
Vilija Jokubaitis
M. Trojano
Alessandra Lugaresi
Giannina Izquierdo
Csilla Rozsa
Pierre Grammond
Raed Alroughani
Pierre Duquette
Marc Girard
Eugenio Pucci
J. Lechner-Scott
M. Slee
R. Fernández Bolaños
F. Grand’Maison
Raymond Hupperts
Freek Verheul
Suzanne J. Hodgkinson
C.Oreja Guevara
D. Spitaleri
Michael Barnett
Murat Terzi
Roberto Bergamaschi
Pamela A. McCombe
J.L. Sánchez Menoyo
Magdolna Simó
Tünde Csépány
G. Rum
C. Boz
Eva Havrdova
Helmut Butzkueven
Keywords:
Multiple sclerosis
Physical therapy
Natalizumab
Fingolimod
Medicine
Oncology
relapsing remitting
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]